F-FET PET/CT影像学数据,根据病理学分级将患者分成低级别胶质瘤组[世界卫生组织(World Health Organization,WHO)Ⅱ级,共计32例]和高级别胶质瘤组(WHO Ⅲ级13例、WHO Ⅳ级13例,共计26例)。在PET、CT影像模态中分别提取105个影像组学特征参数进行分析,采用基于R语言机器学习算法的5折交叉验证最小绝对收缩与选择算子(least absolute shrinkage and selection operator,LASSO)回归分析方法,构建成人胶质瘤病理学分级的3个独立的影像组学预测模型(PET-Rad模型、CT-Rad模型和PET/CT-Rad模型),然后再采用全子集回归对影像组学预测模型进行校正。采用受试者工作特征曲线的曲线下面积(area under curve,AUC)对预测模型进行评价。
结果:
基于4个
18
F-FET PET影像组学参数建立PET-Rad模型的AUC为0.845(95% CI 0.726~0.927);基于3个CT影像组学参数构建的CT-Rad模型的AUC为0.802(95% CI 0.676~0.895);而联合3个CT和2个PET影像组学特征的
18
F-FET PET/CT-Rad模型的AUC为0.901(95% CI 0.794~0.964),准确度为86.21%。DeLong检验结果显示PET/CT-Rad模型优于CT-Rad模型(
and investigate the predictive efficacy for tumor grading in untreated adult gliomas.
Methods:
The
18
F-FET PET/CT imaging data of 58 histopathologically confirmed untreated adult gliomas were retrospectively analyzed. Based on pathological grading
the patients were divided into low-grade glioma groups [World Health Organization (WHO) Grade Ⅱ
32 cases in total] and high-grade gliomas (13 cases for WHO grade Ⅲ
13 cases for WHO grade Ⅳ
26 cases in total). 105 radiomics features were extracted from PET and CT modalities respectively. Five-fold cross-validation least absolute shrinkage and selection operator (LASSO) regression analysis based on R-language machine learning algorithm and all- subset regression were adopted to filter and optimize the identify the optimal feature combinations with higher distinguishing power for glioma grading. Three independent radiomics prediction models (PET-Rad model
CT-Rad model and PET/CT-Rad model) for adult glioma pathological grading were constructed. The area under the receiver operating characteristic curve (AUC) was used to evaluate the prediction model.
Results:
The AUC of PET-Rad model based on four
18
F-FET PET radiomics features was 0.845 (95% CI 0.726-0.927) and the AUC of CT-Rad model consisting of three CT radiomics features was 0.802 (95% CI 0.676-0.895). The AUC of the
18
F-FET PET/ CT-Rad model combined with three CT and two PET radiomics features was 0.901 (95% CI 0.794-0.964)
and the accuracy was 86.21%. DeLong test results
showed that PET/CT-Rad model was superior to CT-Rad model (
P
=0.032). The efficacy of PET/CT-Rad model was better than that of PET-Rad model
but there was no statistical difference (
P
=0.146). The three CT imaging parameters in PET/CT-Rad model were firstorder_10Percentile
glrlm_LowGrayLevelRunEmphasis
and ngtdm_Busyness
while Glrlm_LowGrayLevelRunEmphasis was the most important predictive variable with a relative importance of 30.97%. The relative importance of the other two selected PET radiomic features firstorder_Maximum and ngtdm_Contrast was 21.99% and 21.01%
respectively.
Conclusion:
The non-invasive prediction model based on the combination of integrated
18
F-FET PET and CT modality radiomic features can effectively help grading the untreated adult glioma
facilitating clinical decision-making for patients with varied glioma grades.
The value of 18 F-FDG PET/CT radiomic features for predicting EGFR gene mutation status in patients with lung adenocarcinoma
Research on a prediction model for superficial lymphoma based on multimodal ultrasound radiomics
Intelligent imaging for precision diagnosis and treatment of pancreatic tumors: current applications and future perspectives
Multi-region radiomics features from enhanced CT combined with clinical risk factors for preoperative prediction of lymphovascular invasion in colon cancer
Evaluation of prostate cancer across different treatment stages using 18F-FDG PET imaging
Related Author
JIANG Xuemei
SHEN Jiaqi
PENG Xiaojuan
LI Peiqi
TAN Xiaofei
DANG Jun
YE Zhenyan
YOU Jinhui
Related Institution
Department of Nuclear Medicine, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China
Medical Imaging School, North Sichuan Medical College, Nanchong
Department of Ultrasonography, Lanzhou University Second Hospital
Department of Radiology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University